4D Molecular Therapeutics, Inc. (FDMT)
8.61
-0.37
(-4.12%)
USD |
NASDAQ |
Mar 20, 16:00
8.63
+0.02
(+0.23%)
After-Hours: 20:00
4D Molecular Therapeutics Total Assets (Quarterly) : 566.71M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
| BioMarin Pharmaceutical, Inc. | 7.594B |
| Imunon, Inc. | 8.988M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 61.05M |
| Shareholders Equity (Quarterly) | 505.66M |
| Debt to Equity Ratio | 0.0423 |
| Current Ratio | 9.393 |
| Net Debt Paydown Yield | 0.16% |